TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35442983

Group type: EXPERIMENTAL
Intervention: Laboratory situation with external incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory situation without external incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online situation with external incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online situation without external incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Public goods game with punishment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Public goods game without punishment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online-worker sample in public goods game
Number of subjects: 0
Study: 33012126

Group type: EXPERIMENTAL
Intervention: Baseline hearing loss
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Negative history of atopy
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Never using hearing aids
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Symptom duration
Number of subjects: 389
Study: 34431478

Group type: EXPERIMENTAL
Intervention: Educational program and disease management smartphone app
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (only attended visits)
Number of subjects: 107
Study: 33219133

Group type: EXPERIMENTAL
Intervention: Aerosol box
Number of subjects: 36

Group type: COMPARATOR
Intervention: No aerosol box
Number of subjects: 36
Study: 34784996

Group type: EXPERIMENTAL
Intervention: Group electronic hand hygiene monitoring systems (GEHHMS)
Number of subjects: 2812

Group type: COMPARATOR
Intervention: Baseline hand hygiene adherence without GEHHMS
Number of subjects: 2812

Group type: EXPERIMENTAL
Intervention: Continuous feedback to units using GEHHMS
Number of subjects: 2812
Study: 34193162

Group type: EXPERIMENTAL
Intervention: Social and behavioural change (SBC) interventions including community volunteers, worship places, and community dialogue sessions.
Number of subjects: 773
Study: 35967104

Group type: EXPERIMENTAL
Intervention: Atacicept 25 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Atacicept 75 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33786484

Group type: EXPERIMENTAL
Intervention: Cold compress applied to the abdomen before IUD insertion
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual management (control group)
Number of subjects: 142
Study: 34505206

Group type: EXPERIMENTAL
Intervention: Lifestyle-focused text message intervention
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Focus groups (n=16)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 160
Study: 34615593

Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 156

Group type: COMPARATOR
Intervention: Intracutaneous suturing
Number of subjects: 156
Study: 32702892

Group type: EXPERIMENTAL
Intervention: Lefamulin
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 1289
Study: 35006304

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 68
Study: 34827492

Group type: EXPERIMENTAL
Intervention: Balance exercise using a real-time postural feedback system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 33009840

Group type: EXPERIMENTAL
Intervention: Short-term Compassion Fatigue Resiliency Program (5 hr per day for 2 days, 10 hr total)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Long-term Compassion Fatigue Resiliency Program (5 weeks, 2 hr per week, 10 hr total)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study: 32305185

Group type: EXPERIMENTAL
Intervention: Anterior repair
Number of subjects: 618

Group type: COMPARATOR
Intervention: Posterior repair
Number of subjects: 618
Study: 32773222

Group type: EXPERIMENTAL
Intervention: 2MACE score in patients with CKD
Number of subjects: 4554

Group type: EXPERIMENTAL
Intervention: 2MACE score in patients without CKD
Number of subjects: 4554

Group type: COMPARATOR
Intervention: CKD presence
Number of subjects: 4554

Group type: COMPARATOR
Intervention: Overall incidence of cardiovascular mortality
Number of subjects: 4554

Group type: COMPARATOR
Intervention: Overall incidence of non-cardiovascular mortality
Number of subjects: 4554

Group type: COMPARATOR
Intervention: c-index of the 2MACE score for MACE
Number of subjects: 4554
Study: 35468994

Group type: EXPERIMENTAL
Intervention: 8-bout WBV
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 16-bout WBV
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 16
Study: 32875813

Group type: COMPARATOR
Intervention: Treatment 1 (T1): Vaccinated against ND+IB on days 7 and 14;
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Treatment 2 (T2): Vaccinated against ND+IB on days 3 and 7, and IBD on day 14;
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Treatment 3 (T3): Vaccinated against ND+IB on days 7 and 21, and IBD on day 14;
Number of subjects: 108
Study: 33709613

Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 32997156

Group type: EXPERIMENTAL
Intervention: Autologous bone graft
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Allogenous bone graft
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Artificial bone graft
Number of subjects: 62

Group type: COMPARATOR
Intervention: No bone graft
Number of subjects: 62
Study: 34767967

Group type: EXPERIMENTAL
Intervention: rTMS therapy with individualized MRI guidance
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Scalp-targeting rules (e.g., Beam F3)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 5 cm rule
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Seed-based connectivity analyses
Number of subjects: 49
Study: 32360090

Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block (FNB) and opioids if required
Number of subjects: 236

Group type: COMPARATOR
Intervention: Conventional pain management using opioids if required
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block (FNB) and opioids if required (subgroup analysis)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Conventional pain management using opioids if required (subgroup analysis)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 236
Study: 36471691

Group type: EXPERIMENTAL
Intervention: SBRT + K + M (Stereotactic Body Radiation Therapy with Pembrolizumab and Trametinib)
Number of subjects: 147

Group type: COMPARATOR
Intervention: SBRT + G (Stereotactic Body Radiation Therapy with Gemcitabine)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: SBRT + K + M
Number of subjects: 147

Group type: COMPARATOR
Intervention: SBRT + G
Number of subjects: 147
Study: 33190615

Group type: EXPERIMENTAL
Intervention: ACTIV (Augmented Community Telerehabilitation Intervention)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 95
Study: 32067259

Group type: EXPERIMENTAL
Intervention: Baseline total metabolic tumor volume (TMTV) measured using SUV41max
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Baseline total metabolic tumor volume (TMTV) measured using SUV4
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Interim PET response measured by ΔSUVmax
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Interim PET response measured by Deauville score
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination of high baseline TMTV and poor iPET response
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: TMTV by SUV41max
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: TMTV by SUV4
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: iPET response by ΔSUVmax
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: iPET response by Deauville
Number of subjects: 76
Study: 36331688

Group type: EXPERIMENTAL
Intervention: Robot-assisted psychosocial intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving intervention by humans only
Number of subjects: 0
Study: 34127252

Group type: EXPERIMENTAL
Intervention: Sugammadex (SUG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Neostigmine (NEO)
Number of subjects: 180
Study: 35296289

Group type: EXPERIMENTAL
Intervention: Information related to AstraZeneca's vaccine safety, misinformation, individual health risks, and public health risks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information campaigns tailored for health workers.
Number of subjects: 0
Study: 34003834

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Number of subjects: 161
Study: 32678785

Group type: EXPERIMENTAL
Intervention: Larger roof hatch opening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard roof hatch opening (control)
Number of subjects: 0
Study: 32891079

Group type: EXPERIMENTAL
Intervention: Affected side cross-training
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Unaffected side cross-training
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 52
Study: 35087233

Group type: EXPERIMENTAL
Intervention: Convidecia (heterologous booster)
Number of subjects: 299

Group type: COMPARATOR
Intervention: CoronaVac (homologous booster)
Number of subjects: 299
Study: 33637064

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronic acid (HA) treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (TMJID patients)
Number of subjects: 60
Study: 33923868

Group type: EXPERIMENTAL
Intervention: Standard Mindfulness-Based Stress Reduction (MBSR) and Mindful Self-Compassion (MSC) training program
Number of subjects: 112

Group type: COMPARATOR
Intervention: Abbreviated Mindfulness-Based Stress Reduction (MBSR) and Mindful Self-Compassion (MSC) training program
Number of subjects: 112
Study: 32396250

Group type: EXPERIMENTAL
Intervention: 40% trichloroacetic acid (TCA) in four sessions within 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cryotherapy (Cryo) using liquid nitrogen in four sessions within 8 weeks
Number of subjects: 60
Study: 35595375

Group type: EXPERIMENTAL
Intervention: Informed Assent (IA) discussions about CPR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study: 33962764

Group type: EXPERIMENTAL
Intervention: Bilateral mediastinal lymphadenectomy (BML)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard lymphadenectomy (SLND)
Number of subjects: 102
Study: 32073676

Group type: EXPERIMENTAL
Intervention: Beta-blockers withdrawal
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (beta-blockers continued)
Number of subjects: 52
Study: 36159218

Group type: EXPERIMENTAL
Intervention: PIPAC in combination with systemic chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard systemic chemotherapy
Number of subjects: 0
Study: 33071207

Group type: EXPERIMENTAL
Intervention: Non-surgical glue (ethyl 2-cyanoacrylate; Glue group)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Catgut sutures (Suture group)
Number of subjects: 126
Study: 35136595

Group type: EXPERIMENTAL
Intervention: Universal home visits to pregnant women and their spouses (two-monthly visits)
Number of subjects: 6931
Study: 34840289

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention for anger management (two individual monthly sessions by a psychologist)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention for anger management
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 33517977

Group type: EXPERIMENTAL
Intervention: sintilimab
Number of subjects: 0

Group type: COMPARATOR
Intervention: docetaxel
Number of subjects: 0
Study: 34734306

Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis
Number of subjects: 102

Group type: COMPARATOR
Intervention: Extracorporeal anastomosis
Number of subjects: 102
Study: 34038558

Group type: EXPERIMENTAL
Intervention: Test meal with 300 mL of tea
Number of subjects: 46

Group type: COMPARATOR
Intervention: Test meal without tea
Number of subjects: 46
Study: 35830119

Group type: EXPERIMENTAL
Intervention: 30 % ET
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 % ACT
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 % THF
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 28 % ET + 2 % DMSO (ET+DMSO)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 15 % ethanol + 15 % THF (ET+THF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 28 % THF + 2 % DMSO (THF+DMSO)
Number of subjects: 36
Study: 32206888

Group type: EXPERIMENTAL
Intervention: Alternating bidirectional approach during the first session
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard under-table approach during all sessions
Number of subjects: 96
Study: 33274687

Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Filgotinib 100 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 36031523

Group type: EXPERIMENTAL
Intervention: Auriculotherapy for 4 minutes
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham auricular acupressure
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 94
Study: 34397687

Group type: EXPERIMENTAL
Intervention: Community-based nutritional counseling intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 108
Study: 32374395

Group type: EXPERIMENTAL
Intervention: Serum cyclohexanone levels measured preoperatively, postoperatively, and 12 hours postoperatively
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Geometric mean cyclohexanone levels
Number of subjects: 85
Study: 35242206

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rehabilitation therapy alone
Number of subjects: 100
Study: 32564645

Group type: EXPERIMENTAL
Intervention: MPH (Methylphenidate)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study: 32558709

Group type: EXPERIMENTAL
Intervention: Ga-exendin-4 PET/CT
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: In-exendin-4 SPECT/CT
Number of subjects: 52
Study: 35226737

Group type: EXPERIMENTAL
Intervention: Conscious sedation
Number of subjects: 345

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 345
Study: 33595906

Group type: EXPERIMENTAL
Intervention: 5 mm entry antrostomy (test group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 10 mm entry antrostomy (control group)
Number of subjects: 20
Study: 35457524

Group type: EXPERIMENTAL
Intervention: Educational intervention (brochure distributed)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 208
Study: 32751463

Group type: EXPERIMENTAL
Intervention: High automation probability jobs
Number of subjects: 95762

Group type: EXPERIMENTAL
Intervention: Low automation probability jobs
Number of subjects: 95762

Group type: EXPERIMENTAL
Intervention: Later years of surveys
Number of subjects: 95762

Group type: COMPARATOR
Intervention: Overall trends
Number of subjects: 95762
Study: 35367657

Group type: EXPERIMENTAL
Intervention: Active cathodal tDCS (1.5 mA, 20 min)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham cathodal tDCS
Number of subjects: 11
Study: 33580553

Group type: EXPERIMENTAL
Intervention: Comprehensive face‐to‐face medicine management consultation with an integrated practice pharmacist within seven days of discharge, followed by a consultation with their general practitioner and further pharmacist consultations as needed.
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 306
Study: 33821507

Group type: EXPERIMENTAL
Intervention: Video intervention featuring an adolescent girl with depression
Number of subjects: 1183

Group type: EXPERIMENTAL
Intervention: Video intervention featuring an adolescent boy with depression
Number of subjects: 1183

Group type: COMPARATOR
Intervention: Video intervention featuring an adolescent girl without depression
Number of subjects: 1183

Group type: COMPARATOR
Intervention: Video intervention featuring an adolescent boy without depression
Number of subjects: 1183

Group type: EXPERIMENTAL
Intervention: All video interventions (depression conditions)
Number of subjects: 1183

Group type: EXPERIMENTAL
Intervention: Racially congruent protagonists
Number of subjects: 1183
Study: 32746928

Group type: COMPARATOR
Intervention: Nudging
Number of subjects: 455

Group type: COMPARATOR
Intervention: Non-salient pricing strategies
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Combination of salient price increases and discounts
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Salient pricing and nudging strategies
Number of subjects: 455
Study: 33686630

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl 100 µg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl 200 µg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oxycodone (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (both doses)
Number of subjects: 16
Study: 32579971

Group type: EXPERIMENTAL
Intervention: Meal-time photography (5.44% of meals)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Taking food photographs
Number of subjects: 137

Group type: COMPARATOR
Intervention: Taking non-food photographs
Number of subjects: 137
Study: 35380740

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg b.i.d.
Number of subjects: 1947

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg b.i.d.
Number of subjects: 1947

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg b.i.d. (prior TNFi failure)
Number of subjects: 1947

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg b.i.d. (prior TNFi failure)
Number of subjects: 1947

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1947
Study: 36183850

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 42
Study: 34507602

Group type: EXPERIMENTAL
Intervention: Insecticide treated nets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 0
Study: 35879705

Group type: EXPERIMENTAL
Intervention: 0.075% ropivacaine and 0.5 µg/mL sufentanil
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine and 0.5 µg/mL sufentanil
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 103
Study: 33170938

Group type: EXPERIMENTAL
Intervention: Self-etch (SEE)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Selective enamel etching + self-etch (SET)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Etch‐and‐rinse with dry dentin (ERDry)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Etch‐and‐rinse with wet dentin (ERWet)
Number of subjects: 50
Study: 34999726

Group type: EXPERIMENTAL
Intervention: Virtual soccer game (experimental group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33031130

Group type: EXPERIMENTAL
Intervention: Nurse-led cardiac rehabilitation and routine care, including a booklet on cardiac rehabilitation and fortnightly telephone reminders.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 0
Study: 33158406

Group type: EXPERIMENTAL
Intervention: Self-reported experience of unwanted childbirth (UC)
Number of subjects: 14537

Group type: EXPERIMENTAL
Intervention: Previous experience of induced abortion, sexual violence, and threat from a partner
Number of subjects: 14537

Group type: EXPERIMENTAL
Intervention: Self-reported good health
Number of subjects: 14537
Study: 34170736

Group type: EXPERIMENTAL
Intervention: Nurse-led educational intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 32928289

Group type: EXPERIMENTAL
Intervention: Bath at 24 hours after birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bath at 2 hours after birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bath at 6 hours after birth
Number of subjects: 0
Study: 36067452

Group type: EXPERIMENTAL
Intervention: First-line chemotherapy with cetuximab (anti-EGFR-chemotherapy)
Number of subjects: 292

Group type: COMPARATOR
Intervention: First-line chemotherapy with bevacizumab (anti-VEGF-chemotherapy)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Later-line anti-EGFR-antibody therapy
Number of subjects: 292
Study: 34407860

Group type: EXPERIMENTAL
Intervention: Focal therapy (specifics not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32427122

Group type: EXPERIMENTAL
Intervention: Yoga intervention (6 sessions of 60 minutes each, starting from week 26 to 37 of pregnancy)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no yoga intervention)
Number of subjects: 84
Study: 33285195

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) with a median dose of 33.3 Gy (range: 27 to 54 Gy) in 5 fractions
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) followed by sorafenib
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 128
Study: 32272505

Group type: EXPERIMENTAL
Intervention: Trials that randomized or mandated hormone therapy
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Trials that did not randomize or mandate endocrine therapy
Number of subjects: 131
Study: 35525865

Group type: EXPERIMENTAL
Intervention: Whole grains diet (75% of total carbohydrates)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Refined grains diet (75% of total carbohydrates)
Number of subjects: 248
Study: 32946820

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg twice daily
Number of subjects: 502

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 502
Study: 36086703

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii CNCM I-745
Number of subjects: 317

Group type: COMPARATOR
Intervention: Bacillus clausii
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Both probiotics
Number of subjects: 317
Study: 34351356

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT) with S-1
Number of subjects: 298

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 298
Study: 34426474

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR)
Number of subjects: 0